However, when using the TransFix®-stabilization solution, there was a significant decrease in the absolute number of CD21-positive B lymphocytes between day 0 and day 1 in the CSF samples in this study, which can result in a wrong phenotyping of a lymphoma. The gene discussed is CR2; the disease is lymphoma.